Bio-Techne's market cap is currently $10.32B. The company's EPS TTM is $0.983; its P/E ratio is 66.36; and it has a dividend yield of 0.49%. Bio-Techne is scheduled to report earnings on February 4, 2025, and the estimated EPS forecast is $0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 1.16B	$ 1.14B	$ 1.11B	$ 931.03M	$ 738.69M
Gross Profit	$ 769.73M	$ 769.82M	$ 756.50M	$ 632.85M	$ 483.19M
Operating Income	$ 206.69M	$ 298.94M	$ 296.59M	$ 149.55M	$ 74.68M
EBITDA	$ 310.37M	$ 460.56M	$ 420.12M	$ 258.47M	$ 373.91M
Net Income	$ 168.10M	$ 285.26M	$ 272.05M	$ 140.41M	$ 229.30M
Balance Sheet
Cash & Short-Term Investments	$ 152.86M	$ 204.31M	$ 247.03M	$ 231.55M	$ 270.89M
Total Assets	$ 2.70B	$ 2.64B	$ 2.29B	$ 2.26B	$ 2.03B
Total Debt	$ 419.54M	$ 454.96M	$ 325.97M	$ 420.55M	$ 433.53M
Net Debt	$ 267.75M	$ 274.39M	$ 153.40M	$ 221.46M	$ 286.90M
Total Liabilities	$ 635.02M	$ 672.18M	$ 593.79M	$ 691.72M	$ 646.40M
Stockholders' Equity	$ 2.07B	$ 1.97B	$ 1.70B	$ 1.57B	$ 1.38B
Cash Flow
Free Cash Flow	$ 236.10M	$ 216.15M	$ 280.36M	$ 307.86M	$ 153.47M
Operating Cash Flow	$ 298.98M	$ 254.39M	$ 325.27M	$ 352.16M	$ 205.22M
Investing Cash Flow	$ -203.03M	$ -265.65M	$ -96.85M	$ -243.52M	$ 27.09M
Financing Cash Flow	$ -122.40M	$ 22.62M	$ -242.85M	$ -62.55M	$ -183.80M

Currency in USD

Bio-Techne Earnings and Revenue History

Income Statement >

Bio-Techne Debt to Assets

Balance Sheet >

Bio-Techne Cash Flow

Cash Flow >

Bio-Techne Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing